GB:0A2V's free cash flow for Q4 2023 was €―. For the 2023 fiscal year, GB:0A2V's free cash flow was decreased by €-1.09B and operating cash flow was €―. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Operating Cash Flow	-	€ 10.26B	€ 3.53B	€ 4.92B	€ 7.42B	€ 7.74B
Investing Cash Flow	-	€ -6.20B	€ -3.56B	€ -7.97B	€ 3.62B	€ -1.06B
Financing Cash Flow	-	€ -8.05B	€ -5.82B	€ -7.06B	€ -6.49B	€ -4.19B
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	-	€ 8.71B	€ 4.25B	€ 3.82B	€ 13.91B	€ 9.43B
Income Tax Paid Supplemental Data	-	-	-	-	€ 2.05B	€ 1.70B
Interest Paid Supplemental Data	-	-	-	-	€ 315.00M	€ 379.00M
Issuance Of Capital Stock	-	€ 195.00M	€ 188.00M	€ 186.00M	€ 203.00M	€ 162.00M
Issuance Of Debt	-	€ -3.90B	€ -1.46B	€ -2.39B	€ 2.02B	€ 2.00B
Repayment Of Debt	-	€ -3.95B	€ -3.01B	€ -2.39B	€ -4.19B	€ -2.33B
Free Cash Flow	-	€ 7.23B	€ 8.32B	€ 2.88B	€ 5.33B	€ 5.93B
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in EUR

Sanofi Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing